RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs in their quest for cancer treatments. The most toxic RIPs, remember, have one domain that interferes with ribosomes, and another that carries them into cells. Melissa Cheung and her colleagues incorporated a peptide that binds to skin cancer cells into the enzymatic part of an RIP, the E. coli Shiga-like toxin. The researchers created a new RIP that specifically kills .skin cancer cells, which are notoriously resistant to established therapies. Some of their results are shown in FIGURE 9.17 . FIGURE 9.17 Effect of an engineered RIP on cancer cells. The model on the left shows the enzyme portion of E. coli Shiga-like toxin engineered to carry a small sequence of amino acids (in blue) that targets skin cancer cells. (Red indicates the active site.) The graph on the right shows the effect of this engineered RIP on human cancer cells of the skin ( ); breast ( ) liver ( ); and prostate ( ). Which cells had the greatest response to an increase in concentration of the engineered RIP?

Question

Want to see more full solutions like this?

Answer 1

Textbook Question

Chapter 9, Problem 1DAA

RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs in their quest for cancer treatments. The most toxic RIPs, remember, have one domain that interferes with ribosomes, and another that carries them into cells. Melissa Cheung and her colleagues incorporated a peptide that binds to skin cancer cells into the enzymatic part of an RIP, the E. coli Shiga-like toxin. The researchers created a new RIP that specifically kills .skin cancer cells, which are notoriously resistant to established therapies. Some of their results are shown in FIGURE 9.17.

Chapter 9, Problem 1DAA, RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs , example 1

FIGURE 9.17 Effect of an engineered RIP on cancer cells. The model on the left shows the enzyme portion of E. coli Shiga-like toxin engineered to carry a small sequence of amino acids (in blue) that targets skin cancer cells. (Red indicates the active site.) The graph on the right shows the effect of this engineered RIP on human cancer cells of the skin ( Chapter 9, Problem 1DAA, RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs , example 2 ); breast () liver (); and prostate ().

Which cells had the greatest response to an increase in concentration of the engineered RIP?

Expert Solution & Answer

Summary Introduction

To determine: The type of cells that had the greatest response to an increase in the concentration of the engineered RIP.

Introduction: Ribosome-inactivating proteins (RIPs) inactivate the ribosomes and prevent protein synthesis in a cell. The toxic RIPs have a domain that makes them enter into the cell and another domain that interferes with the ribosome. They have antiviral and anticancer properties and are used to design drugs for HIV and cancer.

Answer to Problem 1DAA

Correct answer: The greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Explanation of Solution

As given in the problem statement, Researcher M and her colleagues incorporated a peptide into the enzymatic part of a RIP, the E. coli Shiga-like toxin. The peptide specifically binds to the skin cancer cells, and thus, the newly synthesized RIP kills the skin cancer cells.

Refer Fig. 9.17, “Effect of an engineered RIP on cancer cells”, in the textbook. The model shown on the left indicates a blue-colored enzyme region of E. coli Shiga-like toxin that is engineered to carry the peptide sequence specific for the skin cancer cells. The red color indicates the active site of RIP.

The graphical representation that is shown in Fig. 9.17 on the right side indicates the effect of the engineered RIP on different human cancer cells indicated by different colors and shapes. They include skin, breast, liver, and prostate cancer cells with red, blue, brown, and green color, respectively. The concentration of RIP (µg/liter) is plotted with the percentage of cell survival. As shown in the graph, as the concentration of RIP increases, there is a significant drop in the skin cancer cells percentage. It reaches to zero at RIP concentration of 10 µg/liter. In the case of the other cancer cells, there is lesser variability.

Thus, the greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Students have asked these similar questions

After you feel comfortable with your counting method and identifying cells in the various stages of mitosis, use the four images below of whitefish blastula to count the cells in each stage until you reach 100 total cells, recording your data below in Data Table 1. (You may not need to use all four images. Stop counting when you reach 100 total cells.) After totaling the cells in each stage, calculate the percent of cells in each stage. (Divide total of stage by overall total of 100 and then multiply by 100 to obtain percentage.) Data Table 1Stage Totals PercentInterphase Mitosis: Prophase Metaphase Anaphase Telophase Cytokinesis Totals 100 100% To find the length of time whitefish blastula cells spend in each stage, multiply the percent (recorded as a decimal, in other words take the percent number and divide by 100) by 24 hours. (Example: If percent is 20%, then Time in Hours = .2 * 24 = 4.8) Record your data in Data…

What are Clathrin coated vesicles and what is their function?

How is a protein destined for the Endoplasmic Reticulum (ER), imported into the ER? Be concise.

Answer 2

Textbook Question

Chapter 9, Problem 1DAA

RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs in their quest for cancer treatments. The most toxic RIPs, remember, have one domain that interferes with ribosomes, and another that carries them into cells. Melissa Cheung and her colleagues incorporated a peptide that binds to skin cancer cells into the enzymatic part of an RIP, the E. coli Shiga-like toxin. The researchers created a new RIP that specifically kills .skin cancer cells, which are notoriously resistant to established therapies. Some of their results are shown in FIGURE 9.17.

Chapter 9, Problem 1DAA, RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs , example 1

FIGURE 9.17 Effect of an engineered RIP on cancer cells. The model on the left shows the enzyme portion of E. coli Shiga-like toxin engineered to carry a small sequence of amino acids (in blue) that targets skin cancer cells. (Red indicates the active site.) The graph on the right shows the effect of this engineered RIP on human cancer cells of the skin ( Chapter 9, Problem 1DAA, RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs , example 2 ); breast () liver (); and prostate ().

Which cells had the greatest response to an increase in concentration of the engineered RIP?

Expert Solution & Answer

Summary Introduction

To determine: The type of cells that had the greatest response to an increase in the concentration of the engineered RIP.

Introduction: Ribosome-inactivating proteins (RIPs) inactivate the ribosomes and prevent protein synthesis in a cell. The toxic RIPs have a domain that makes them enter into the cell and another domain that interferes with the ribosome. They have antiviral and anticancer properties and are used to design drugs for HIV and cancer.

Answer to Problem 1DAA

Correct answer: The greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Explanation of Solution

As given in the problem statement, Researcher M and her colleagues incorporated a peptide into the enzymatic part of a RIP, the E. coli Shiga-like toxin. The peptide specifically binds to the skin cancer cells, and thus, the newly synthesized RIP kills the skin cancer cells.

Refer Fig. 9.17, “Effect of an engineered RIP on cancer cells”, in the textbook. The model shown on the left indicates a blue-colored enzyme region of E. coli Shiga-like toxin that is engineered to carry the peptide sequence specific for the skin cancer cells. The red color indicates the active site of RIP.

The graphical representation that is shown in Fig. 9.17 on the right side indicates the effect of the engineered RIP on different human cancer cells indicated by different colors and shapes. They include skin, breast, liver, and prostate cancer cells with red, blue, brown, and green color, respectively. The concentration of RIP (µg/liter) is plotted with the percentage of cell survival. As shown in the graph, as the concentration of RIP increases, there is a significant drop in the skin cancer cells percentage. It reaches to zero at RIP concentration of 10 µg/liter. In the case of the other cancer cells, there is lesser variability.

Thus, the greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 3

Textbook Question

Chapter 9, Problem 1DAA

RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs in their quest for cancer treatments. The most toxic RIPs, remember, have one domain that interferes with ribosomes, and another that carries them into cells. Melissa Cheung and her colleagues incorporated a peptide that binds to skin cancer cells into the enzymatic part of an RIP, the E. coli Shiga-like toxin. The researchers created a new RIP that specifically kills .skin cancer cells, which are notoriously resistant to established therapies. Some of their results are shown in FIGURE 9.17.

Chapter 9, Problem 1DAA, RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs , example 1

FIGURE 9.17 Effect of an engineered RIP on cancer cells. The model on the left shows the enzyme portion of E. coli Shiga-like toxin engineered to carry a small sequence of amino acids (in blue) that targets skin cancer cells. (Red indicates the active site.) The graph on the right shows the effect of this engineered RIP on human cancer cells of the skin ( Chapter 9, Problem 1DAA, RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs , example 2 ); breast () liver (); and prostate ().

Which cells had the greatest response to an increase in concentration of the engineered RIP?

Expert Solution & Answer

Summary Introduction

To determine: The type of cells that had the greatest response to an increase in the concentration of the engineered RIP.

Introduction: Ribosome-inactivating proteins (RIPs) inactivate the ribosomes and prevent protein synthesis in a cell. The toxic RIPs have a domain that makes them enter into the cell and another domain that interferes with the ribosome. They have antiviral and anticancer properties and are used to design drugs for HIV and cancer.

Answer to Problem 1DAA

Correct answer: The greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Explanation of Solution

As given in the problem statement, Researcher M and her colleagues incorporated a peptide into the enzymatic part of a RIP, the E. coli Shiga-like toxin. The peptide specifically binds to the skin cancer cells, and thus, the newly synthesized RIP kills the skin cancer cells.

Refer Fig. 9.17, “Effect of an engineered RIP on cancer cells”, in the textbook. The model shown on the left indicates a blue-colored enzyme region of E. coli Shiga-like toxin that is engineered to carry the peptide sequence specific for the skin cancer cells. The red color indicates the active site of RIP.

The graphical representation that is shown in Fig. 9.17 on the right side indicates the effect of the engineered RIP on different human cancer cells indicated by different colors and shapes. They include skin, breast, liver, and prostate cancer cells with red, blue, brown, and green color, respectively. The concentration of RIP (µg/liter) is plotted with the percentage of cell survival. As shown in the graph, as the concentration of RIP increases, there is a significant drop in the skin cancer cells percentage. It reaches to zero at RIP concentration of 10 µg/liter. In the case of the other cancer cells, there is lesser variability.

Thus, the greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 4

Textbook Question

Chapter 9, Problem 1DAA

RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs in their quest for cancer treatments. The most toxic RIPs, remember, have one domain that interferes with ribosomes, and another that carries them into cells. Melissa Cheung and her colleagues incorporated a peptide that binds to skin cancer cells into the enzymatic part of an RIP, the E. coli Shiga-like toxin. The researchers created a new RIP that specifically kills .skin cancer cells, which are notoriously resistant to established therapies. Some of their results are shown in FIGURE 9.17.

Chapter 9, Problem 1DAA, RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs , example 1

FIGURE 9.17 Effect of an engineered RIP on cancer cells. The model on the left shows the enzyme portion of E. coli Shiga-like toxin engineered to carry a small sequence of amino acids (in blue) that targets skin cancer cells. (Red indicates the active site.) The graph on the right shows the effect of this engineered RIP on human cancer cells of the skin ( Chapter 9, Problem 1DAA, RIPs as Cancer Drugs Researchers are taking a page from the structure-function relationship of RIPs , example 2 ); breast () liver (); and prostate ().

Which cells had the greatest response to an increase in concentration of the engineered RIP?

Expert Solution & Answer

Summary Introduction

To determine: The type of cells that had the greatest response to an increase in the concentration of the engineered RIP.

Introduction: Ribosome-inactivating proteins (RIPs) inactivate the ribosomes and prevent protein synthesis in a cell. The toxic RIPs have a domain that makes them enter into the cell and another domain that interferes with the ribosome. They have antiviral and anticancer properties and are used to design drugs for HIV and cancer.

Answer to Problem 1DAA

Correct answer: The greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Explanation of Solution

As given in the problem statement, Researcher M and her colleagues incorporated a peptide into the enzymatic part of a RIP, the E. coli Shiga-like toxin. The peptide specifically binds to the skin cancer cells, and thus, the newly synthesized RIP kills the skin cancer cells.

Refer Fig. 9.17, “Effect of an engineered RIP on cancer cells”, in the textbook. The model shown on the left indicates a blue-colored enzyme region of E. coli Shiga-like toxin that is engineered to carry the peptide sequence specific for the skin cancer cells. The red color indicates the active site of RIP.

The graphical representation that is shown in Fig. 9.17 on the right side indicates the effect of the engineered RIP on different human cancer cells indicated by different colors and shapes. They include skin, breast, liver, and prostate cancer cells with red, blue, brown, and green color, respectively. The concentration of RIP (µg/liter) is plotted with the percentage of cell survival. As shown in the graph, as the concentration of RIP increases, there is a significant drop in the skin cancer cells percentage. It reaches to zero at RIP concentration of 10 µg/liter. In the case of the other cancer cells, there is lesser variability.

Thus, the greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 5

Textbook Question

Answer 6

Textbook Question

Answer 7

Expert Solution & Answer

Summary Introduction

To determine: The type of cells that had the greatest response to an increase in the concentration of the engineered RIP.

Introduction: Ribosome-inactivating proteins (RIPs) inactivate the ribosomes and prevent protein synthesis in a cell. The toxic RIPs have a domain that makes them enter into the cell and another domain that interferes with the ribosome. They have antiviral and anticancer properties and are used to design drugs for HIV and cancer.

Answer to Problem 1DAA

Correct answer: The greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Explanation of Solution

As given in the problem statement, Researcher M and her colleagues incorporated a peptide into the enzymatic part of a RIP, the E. coli Shiga-like toxin. The peptide specifically binds to the skin cancer cells, and thus, the newly synthesized RIP kills the skin cancer cells.

Refer Fig. 9.17, “Effect of an engineered RIP on cancer cells”, in the textbook. The model shown on the left indicates a blue-colored enzyme region of E. coli Shiga-like toxin that is engineered to carry the peptide sequence specific for the skin cancer cells. The red color indicates the active site of RIP.

The graphical representation that is shown in Fig. 9.17 on the right side indicates the effect of the engineered RIP on different human cancer cells indicated by different colors and shapes. They include skin, breast, liver, and prostate cancer cells with red, blue, brown, and green color, respectively. The concentration of RIP (µg/liter) is plotted with the percentage of cell survival. As shown in the graph, as the concentration of RIP increases, there is a significant drop in the skin cancer cells percentage. It reaches to zero at RIP concentration of 10 µg/liter. In the case of the other cancer cells, there is lesser variability.

Thus, the greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Answer 8

Expert Solution & Answer

Summary Introduction

To determine: The type of cells that had the greatest response to an increase in the concentration of the engineered RIP.

Introduction: Ribosome-inactivating proteins (RIPs) inactivate the ribosomes and prevent protein synthesis in a cell. The toxic RIPs have a domain that makes them enter into the cell and another domain that interferes with the ribosome. They have antiviral and anticancer properties and are used to design drugs for HIV and cancer.

Answer to Problem 1DAA

Correct answer: The greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Explanation of Solution

As given in the problem statement, Researcher M and her colleagues incorporated a peptide into the enzymatic part of a RIP, the E. coli Shiga-like toxin. The peptide specifically binds to the skin cancer cells, and thus, the newly synthesized RIP kills the skin cancer cells.

Refer Fig. 9.17, “Effect of an engineered RIP on cancer cells”, in the textbook. The model shown on the left indicates a blue-colored enzyme region of E. coli Shiga-like toxin that is engineered to carry the peptide sequence specific for the skin cancer cells. The red color indicates the active site of RIP.

The graphical representation that is shown in Fig. 9.17 on the right side indicates the effect of the engineered RIP on different human cancer cells indicated by different colors and shapes. They include skin, breast, liver, and prostate cancer cells with red, blue, brown, and green color, respectively. The concentration of RIP (µg/liter) is plotted with the percentage of cell survival. As shown in the graph, as the concentration of RIP increases, there is a significant drop in the skin cancer cells percentage. It reaches to zero at RIP concentration of 10 µg/liter. In the case of the other cancer cells, there is lesser variability.

Thus, the greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Answer 9

Expert Solution & Answer

Answer 10

Expert Solution & Answer

Answer 11

Summary Introduction

To determine: The type of cells that had the greatest response to an increase in the concentration of the engineered RIP.

Introduction: Ribosome-inactivating proteins (RIPs) inactivate the ribosomes and prevent protein synthesis in a cell. The toxic RIPs have a domain that makes them enter into the cell and another domain that interferes with the ribosome. They have antiviral and anticancer properties and are used to design drugs for HIV and cancer.

Answer 12

Answer to Problem 1DAA

Correct answer: The greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Answer 13

Explanation of Solution

As given in the problem statement, Researcher M and her colleagues incorporated a peptide into the enzymatic part of a RIP, the E. coli Shiga-like toxin. The peptide specifically binds to the skin cancer cells, and thus, the newly synthesized RIP kills the skin cancer cells.

Refer Fig. 9.17, “Effect of an engineered RIP on cancer cells”, in the textbook. The model shown on the left indicates a blue-colored enzyme region of E. coli Shiga-like toxin that is engineered to carry the peptide sequence specific for the skin cancer cells. The red color indicates the active site of RIP.

The graphical representation that is shown in Fig. 9.17 on the right side indicates the effect of the engineered RIP on different human cancer cells indicated by different colors and shapes. They include skin, breast, liver, and prostate cancer cells with red, blue, brown, and green color, respectively. The concentration of RIP (µg/liter) is plotted with the percentage of cell survival. As shown in the graph, as the concentration of RIP increases, there is a significant drop in the skin cancer cells percentage. It reaches to zero at RIP concentration of 10 µg/liter. In the case of the other cancer cells, there is lesser variability.

Thus, the greatest response in the form of fall in cell’s survival percentage with an increase in the concentration of engineered RIP is seen in the skin cancer cells.

Answer 14

Ch. 9 - RIPs as Cancer Drugs Researchers are taking a page...Ch. 9 - RIPs as Cancer Drugs Researchers are taking a page...Ch. 9 - RIPs as Cancer Drugs Researchers are taking a page...Ch. 9 - RIPs as Cancer Drugs Researchers are taking a page...Ch. 9 - A chromosome contains many different genes that...Ch. 9 - A binding .site for RNA polymerase is called a ___...Ch. 9 - In cells, most RNA molecules are ___ ; most DNA...Ch. 9 - Prob. 4SQ Ch. 9 - The main function of a DNA molecule is to ________...Ch. 9 - The main function of an mRNA molecule is to ___ ....

Concept explainers

Videos

Answer to Problem 1DAA

Explanation of Solution

Want to see more full solutions like this?

Chapter 9 Solutions

Additional Science Textbook Solutions